» Articles » PMID: 37510779

Crural and Plantar Fasciae Changes in Chronic Charcot Diabetic Foot: A Cross-Sectional Ultrasound Imaging Study-An Evidence of Fascial Continuity

Overview
Journal J Clin Med
Specialty General Medicine
Date 2023 Jul 29
PMID 37510779
Authors
Affiliations
Soon will be listed here.
Abstract

Crural fascia (CF) and plantar fascia (PF) are biomechanically crucial in the gait and in the proprioception, particularly in the propulsion phase of the foot during the gait cycle and in the dissipation of forces during weight-bearing activities. Recent studies have revealed an association between increases in PF thickness and diabetes. The purpose of this study was to measure and compare by ultrasound (US) imaging the thickness of the CF and PF at different regions/levels in chronic Charcot diabetic foot patients (group 1) and in healthy volunteers (group 2). A cross-sectional study was performed using US imaging to measure the CF with Pirri et al.'s protocol and PF with a new protocol in a sample of 31 subjects (15 patients and 16 healthy participants). The findings for CF and PF revealed statistically significant differences in the poster region of CF (Post 1: group 1 vs. group 2: = 0.03; Post 2: group 1 vs. group 2: = 0.03) and in PF at two different levels (PF level 1: group 1 vs. group 2: < 0.0001; PF level 2: group 1 vs. group 2: < 0.0001). These findings suggest that chronic Charcot diabetic foot patients have CF and PF thicker compared to healthy volunteers. The US examination suggests that fascial thicknesses behavior in these patients points out altered fascial remodeling due to diabetes pathology and biomechanical changes.

Citing Articles

Editorial: Fascia as a multi-purpose structure of connective tissue - dysfunction, diagnostics and treatment.

Mika A, Oleksy L, Fede C, Pirri C, Stecco C Front Med (Lausanne). 2024; 11:1472116.

PMID: 39206164 PMC: 11349619. DOI: 10.3389/fmed.2024.1472116.


Program with last minute abstracts of the Padua Days on Muscle and Mobility Medicine, 27 February - 2 March, 2024 (2024Pdm3).

Zampieri S, Bersch I, Smeriglio P, Barbieri E, Boncompagni S, Maccarone M Eur J Transl Myol. 2024; .

PMID: 38305708 PMC: 11017178. DOI: 10.4081/ejtm.2024.12346.


Five Padua days on muscle and mobility medicine (2024Pdm3) 27 February - 2 March, 2024 at Hotel Petrarca, Thermae of Euganean Hills, Padua, and San Luca Hall, Prato della Valle, Padua, Italy.

Zampieri S, Bersch I, Smeriglio P, Barbieri E, Ganassi M, Leeuwenburg C Eur J Transl Myol. 2023; 33(4).

PMID: 38112609 PMC: 10811652. DOI: 10.4081/ejtm.2023.12161.

References
1.
Abate M, Schiavone C, Di Carlo L, Salini V . Achilles tendon and plantar fascia in recently diagnosed type II diabetes: role of body mass index. Clin Rheumatol. 2012; 31(7):1109-13. DOI: 10.1007/s10067-012-1955-y. View

2.
Khor B, Woodburn J, Newcombe L, Barn R . Plantar soft tissues and Achilles tendon thickness and stiffness in people with diabetes: a systematic review. J Foot Ankle Res. 2021; 14(1):35. PMC: 8080343. DOI: 10.1186/s13047-021-00475-7. View

3.
von Elm E, Altman D, Egger M, Pocock S, Gotzsche P, Vandenbroucke J . The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008; 61(4):344-9. DOI: 10.1016/j.jclinepi.2007.11.008. View

4.
Fede C, Pirri C, Petrelli L, Guidolin D, Fan C, De Caro R . Sensitivity of the Fasciae to the Endocannabinoid System: Production of Hyaluronan-Rich Vesicles and Potential Peripheral Effects of Cannabinoids in Fascial Tissue. Int J Mol Sci. 2020; 21(8). PMC: 7216169. DOI: 10.3390/ijms21082936. View

5.
Ferreira R . Diabetic Foot. Part 2: Charcot Neuroarthropathy. Rev Bras Ortop (Sao Paulo). 2020; 55(4):397-403. PMC: 7458761. DOI: 10.1055/s-0039-3402460. View